Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group-Reference-Cited by-同舟云学术

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group

Published:2014-03 Issue:1 Volume:233 Page:83-90
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Langlois Michel R.,Descamps Olivier S.,van der Laarse Arnoud,Weykamp Cas,Baum Hannsjörg,Pulkki Kari,von Eckardstein Arnold,De Bacquer Dirk,Borén Jan,Wiklund Olov,Laitinen Païvi,Oosterhuis Wytze P.,Cobbaert Christa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. ESC/EAS guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Catapano;Atherosclerosis,2011

2. A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE;Descamps;Atherosclerosis,2012

3. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals;Haase;J Clin Endocrinol Metab,2012

4. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study;Voight;Lancet,2012

5. Historical milestones in the measurement of HDL cholesterol: impact on clinical and laboratory practice;Langlois;Clin Chim Acta,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Labordiagnostik von Fettstoffwechselstörungen;Diabetes aktuell;2024-05

2. The value of Lp(a) and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke;Brain and Behavior;2024-01

3. Association Between ALDH2 Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients;International Journal of General Medicine;2023-12

4. Nebenwirkungen von GLP-1-Agonisten als Abnehmmittel;DMW - Deutsche Medizinische Wochenschrift;2023-11

5. Labordiagnostik von Fettstoffwechselstörungen;DMW - Deutsche Medizinische Wochenschrift;2023-11